IMPLANET Reports an Improvement in Its 2021 Half-year Results
H1 2021 revenue up 43% to €3.7 million Sharp increase in gross margin to 61.2%, vs. 55.7% in H1 2020...
H1 2021 revenue up 43% to €3.7 million Sharp increase in gross margin to 61.2%, vs. 55.7% in H1 2020...
Immunotherapy device intended to safely filter-out IL-6 cytokine through novel subtractive therapy Initiation of pre-clinical program is critical first step...
Veris remote digital healthcare platform to utilize first intelligent implantable vascular access port with biologic sensors and wireless communication to...
AUSTIN, Texas, Sept. 21, 2021 /PRNewswire/ -- The CSD Unites Community Foundation, a division of Communication Service for the Deaf, is seeking...
SURREY, BC / ACCESSWIRE / September 21, 2021 / Eversio Wellness Ltd. ("Eversio" or the "Company"), a mushroom wellness company,...
Strong Demand and Expanded Product Offerings Push August to Record SalesDENVER, CO / ACCESSWIRE / September 21, 2021 / Leafbuyer...
HAMILTON, BERMUDA / ACCESSWIRE / September 21, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical...
LAS VEGAS, NV / ACCESSWIRE / September 21, 2021 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...
An Internationally Recognized Authority in Dry Eye Disease, Dr. Tauber has Participated in over 140 Research Studies as Principal Investigator...
SAN DIEGO, CA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary...
New York, NY, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The C3 Summit is a renowned gathering that fosters US-Arab Healthcare...
SYDNEY, Australia, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Dr. Rønø has developed Evaxion's pre-clinical and early clinical oncology pipelineNewly-created Chief Scientific Officer role strengthens Evaxion's leadership teamCOPENHAGEN, Denmark,...
Loughborough, England, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing...
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel,...
33 early and late-stage clinical programs across modalities and innovative discovery platformsUniquely positioned to lead in Alzheimer’s disease with ADUHELM®...
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on...
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- LifeSci Partners, a life-sciences focused consultancy, today announced that it has entered...
Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device ManufacturersMALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE)...
Live fireside chat with C. Russell Trenary, President and CEO of Outlook Therapeutics on Tuesday, September 28 at 2:00 PM...